Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nagavendra Kommineni

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
International Journal of Molecular Sciences|June 19, 2024
Special Issue "Latest Advances in Nanomedicine Strategies for Different Diseases"Nagavendra Kommineni, Veera Ganesh Yerra
Pharmacological Research|May 18, 2017
Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer TherapyEameema Muntimadugu, Nagavendra Kommineni, Wahid Khan
Nanomaterials (Basel, Switzerland)|July 2, 2021
Exosomes as Naturally Occurring Vehicles for Delivery of Biopharmaceuticals: Insights from Drug Delivery to Clinical PerspectivesArun Butreddy, Nagavendra Kommineni, Narendar Dudhipala
Nanotheranostics|July 4, 2024
Peptide Conjugated Boron Neutron Capture Therapy for Enhanced Tumor TargetingVaskuri G S Sainaga Jyothi, Nagavendra Kommineni
Pharmaceutics|March 28, 2017
Liposomal Formulations in Clinical Use: An Updated ReviewUpendra Bulbake, Sindhu Doppalapudi, Nagavendra Kommineni, et al.
Chemistry and Physics of Lipids|December 7, 2018
Cabazitaxel and thymoquinone co-loaded lipospheres as a synergistic combination for breast cancerNagavendra Kommineni, Raju Saka, Upendra Bulbake, et al.
ACS Applied Bio Materials|July 1, 2024
Nanofibrous Microspheres: A Biomimetic Platform for Bone Tissue RegenerationNimeet Desai, Shreya Pande, Lalitkumar K Vora, et al.
Drug Delivery and Translational Research|August 12, 2017
Non-polymer drug-eluting coronary stentsNagavendra Kommineni, Raju Saka, Wahid Khan, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 17, 2018
Cabazitaxel and silibinin co-encapsulated cationic liposomes for CD44 targeted delivery: A new insight into nanomedicine based combinational chemotherapy for prostate cancerShaheen Mahira, Nagavendra Kommineni, Gulam Mohammed Husain, et al.
Pharmaceutics|April 3, 2019
Cabazitaxel-Loaded Nanocarriers for Cancer Therapy with Reduced Side EffectsNagavendra Kommineni, Shaheen Mahira, Abraham J Domb, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
International Journal of Molecular Sciences|June 19, 2024
Special Issue "Latest Advances in Nanomedicine Strategies for Different Diseases"Nagavendra Kommineni, Veera Ganesh Yerra
Pharmacological Research|May 18, 2017
Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer TherapyEameema Muntimadugu, Nagavendra Kommineni, Wahid Khan
Nanomaterials (Basel, Switzerland)|July 2, 2021
Exosomes as Naturally Occurring Vehicles for Delivery of Biopharmaceuticals: Insights from Drug Delivery to Clinical PerspectivesArun Butreddy, Nagavendra Kommineni, Narendar Dudhipala
Nanotheranostics|July 4, 2024
Peptide Conjugated Boron Neutron Capture Therapy for Enhanced Tumor TargetingVaskuri G S Sainaga Jyothi, Nagavendra Kommineni
Pharmaceutics|March 28, 2017
Liposomal Formulations in Clinical Use: An Updated ReviewUpendra Bulbake, Sindhu Doppalapudi, Nagavendra Kommineni, et al.
Chemistry and Physics of Lipids|December 7, 2018
Cabazitaxel and thymoquinone co-loaded lipospheres as a synergistic combination for breast cancerNagavendra Kommineni, Raju Saka, Upendra Bulbake, et al.
ACS Applied Bio Materials|July 1, 2024
Nanofibrous Microspheres: A Biomimetic Platform for Bone Tissue RegenerationNimeet Desai, Shreya Pande, Lalitkumar K Vora, et al.
Drug Delivery and Translational Research|August 12, 2017
Non-polymer drug-eluting coronary stentsNagavendra Kommineni, Raju Saka, Wahid Khan, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 17, 2018
Cabazitaxel and silibinin co-encapsulated cationic liposomes for CD44 targeted delivery: A new insight into nanomedicine based combinational chemotherapy for prostate cancerShaheen Mahira, Nagavendra Kommineni, Gulam Mohammed Husain, et al.
Pharmaceutics|April 3, 2019
Cabazitaxel-Loaded Nanocarriers for Cancer Therapy with Reduced Side EffectsNagavendra Kommineni, Shaheen Mahira, Abraham J Domb, et al.
Pageof 6